Effects of Kettlebell Swing Training Combined With Breathing Exercises on Respiratory Muscle Strength and Pulmonary Function in Overweight and Obese Young Adults (Kettlebell)
Overweight and obesity are associated with impaired breathing mechanics, including reduced chest wall and diaphragmatic movement, decreased respiratory muscle strength and endurance, and inefficient breathing patterns. These changes may adversely affect pulmonary function, autonomic regulation, and physical capacity.
This study aims to compare the effects of kettlebell swing exercise combined with breathing training versus breathing training alone in individuals with overweight or obesity. Outcomes will include respiratory muscle strength, pulmonary function, heart rate variability, and body composition. The findings may help determine whether adding kettlebell swing exercise to breathing training provides additional benefits for respiratory and cardiometabolic health in this population.
調査の概要
詳細な説明
A total of 40 young adults aged 18-25 years with overweight or obesity (body mass index [BMI] ≥23.0 kg/m²) will be recruited and randomly assigned to one of two groups.
The experimental group will perform kettlebell swing exercise combined with breathing training for 40 minutes per session. The control group will receive breathing training alone for 20 minutes per session. Both groups will participate in their assigned intervention three times per week for 6 weeks.
Outcome measures will include respiratory muscle strength, pulmonary function, heart rate variability (HRV), and body composition.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Pacharee Manoy, Ph.D.
- 電話番号：Thailand: +66 (54) 466 697
- メール：pachareeman@gmail.com
研究連絡先のバックアップ
- 名前：Patchareeya Amput, Ph.D.
- 電話番号：Thailand: +66 (54) 466 697
- メール：patchareeya.am@up.ac.th
研究場所
-
-
Changwat Phayao
-
Phayao、Changwat Phayao、タイ、56000
- 募集
- School of Allied Health Sciences, University of Phayao
-
コンタクト：
- Pacharee Manoy, Ph.D.
- 電話番号：3339 Thailand: +66 (54) 466 666
- メール：pacharee.ma@up.ac.th
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
Inclusion Criteria:
- Male or female adults aged 18-25 years with a body mass index (BMI) of ≥23.0 kg/m².
- Individuals who are physically inactive or sedentary, defined as exercising fewer than 3 days per week or engaging in less than 150 minutes of exercise per week.
- Willingness to provide written informed consent to participate in the study.
Exclusion Criteria:
- Presence of bodily pain, particularly in the upper or lower extremities, with a Visual Analogue Scale (VAS) score of >3/10.
- Musculoskeletal disorders, such as scoliosis.
- History of neurological disorders, including spinal cord injury, epilepsy, or stroke.
- History of respiratory or cardiovascular diseases, including hypertension, heart disease, emphysema, asthma, previous lung lobectomy, or lung cancer.
- History of chronic non-communicable diseases or other systemic disorders, including diabetes mellitus, kidney disease, liver disease, endocrine disorders, or immune system disorders.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：防止
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Experimental group
Kettlebell swing training combined with breathing exercises
|
Kettlebell swing training combined with breathing exercises, performed three times per week for 40 minutes per session over 6 weeks.
|
|
偽コンパレータ：Control group
Breathing exercises
|
Breathing exercises performed three times per week for 20 minutes per session over 6 weeks.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Repiratory muscle strength
時間枠：Before and after the 6 week intervention
|
Respiratory muscle strength will be measured using a handheld manometer (MicroRPM).
Participants will be instructed to perform a maximal inspiratory effort from residual volume to assess maximal inspiratory pressure (PImax) and a maximal expiratory effort from total lung capacity to assess maximal expiratory pressure (PEmax).
|
Before and after the 6 week intervention
|
|
Heart rate variability (HRV)
時間枠：Before and after the 6 week intervention
|
Time and frequency-domain heart rate variability (HRV) parameters will be measured using the SA-3000P analyzer.
|
Before and after the 6 week intervention
|
|
Pulmonary function test
時間枠：Before and after the 6 week intervention
|
Vital capacity (VC), expiratory reserve volume (ERV), forced vital capacity (FVC), forced expiratory volume in 1 second (FEV₁), and the FEV₁/FVC ratio will be measured using a portable spirometer.
|
Before and after the 6 week intervention
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Body composition
時間枠：Before and after the 6 week intervention
|
Muscle mass and fat mass will be assessed using bioelectrical impedance analysis (BIA).
|
Before and after the 6 week intervention
|
協力者と研究者
スポンサー
出版物と役立つリンク
便利なリンク
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- HREC-UP-HSST 1.2/111/69
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。